Grade | Pre-ERAS | Post-ERAS | P value | |
Gastrointestinal complications | ≥2 | 8 (3%) | 11 (6%) | 0.25 |
Genitourinary complications | ≥2 | 0 | 3 (2%) | 0.088 |
Urinary tract infection | ≥2 | 19 (8%) | 16 (8%) | 1.0 |
Infection* | ≥2 | 28 (12%) | 26 (13%) | 0.86 |
Skin/wound complications | ≥2 | 18 (7%) | 10 (5%) | 0.43 |
Anemia | ≥2 | 46 (19%) | 37 (19%) | 1.0 |
Cardiovascular complications | ≥2 | 6 (2%) | 8 (4%) | 0.41 |
Respiratory complications | ≥2 | 7 (3%) | 15 (8%) | 0.028 |
Neurological complications | ≥2 | 0 | 1 (1%) | 0.31 |
Metabolic complications | ≥2 | 2 (1%) | 1 (1%) | 1.0 |
Other | ≥2 | 20 (8%) | 18 (9%) | 0.74 |
*Including urinary tract infection, excluding skin/wound infections.
ERAS, enhanced recovery after surgery.